| Style | Citing Format |
|---|---|
| MLA | Shakshouk H, et al.. "Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic." Journal of the American Academy of Dermatology, vol. 82, no. 6, 2020, pp. e235-e236. |
| APA | Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS (2020). Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic. Journal of the American Academy of Dermatology, 82(6), e235-e236. |
| Chicago | Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. "Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic." Journal of the American Academy of Dermatology 82, no. 6 (2020): e235-e236. |
| Harvard | Shakshouk H et al. (2020) 'Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic', Journal of the American Academy of Dermatology, 82(6), pp. e235-e236. |
| Vancouver | Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic. Journal of the American Academy of Dermatology. 2020;82(6):e235-e236. |
| BibTex | @article{ author = {Shakshouk H and Daneshpazhooh M and Murrell DF and Lehman JS}, title = {Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic}, journal = {Journal of the American Academy of Dermatology}, volume = {82}, number = {6}, pages = {e235-e236}, year = {2020} } |
| RIS | TY - JOUR AU - Shakshouk H AU - Daneshpazhooh M AU - Murrell DF AU - Lehman JS TI - Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic JO - Journal of the American Academy of Dermatology VL - 82 IS - 6 SP - e235 EP - e236 PY - 2020 ER - |